SSRI use and clinical outcomes in epithelial ovarian cancer

Selective serotonin reuptake inhibitor (SSRI) use is common among ovarian cancer patients. We examined the effect of SSRIs on survival and progression in ovarian cancer patients and effects of 5-HT on ovarian cancer cell (OCC) proliferation. Ovarian cancer patients from a 6-site study between 1994 a...

Descripción completa

Detalles Bibliográficos
Autores principales: Christensen, Desiré K., Armaiz-Pena, Guillermo N., Ramirez, Edgardo, Matsuo, Koji, Zimmerman, Bridget, Zand, Behrouz, Shinn, Eileen, Goodheart, Michael J., Bender, David, Thaker, Premal H., Ahmed, Amina, Penedo, Frank J., DeGeest, Koen, Mendez, Luis, Domann, Frederick, Sood, Anil K., Lutgendorf, Susan K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5078084/
https://www.ncbi.nlm.nih.gov/pubmed/27121207
http://dx.doi.org/10.18632/oncotarget.8891

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5078084/
https://www.ncbi.nlm.nih.gov/pubmed/27121207
http://dx.doi.org/10.18632/oncotarget.8891

Ejemplares similares